Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Dr. Daniel Koller shares his views on the biotech sector in the interview with Edison. He expands on themes like the sector’s ability to outperform the broader equity market as the market moves forward and  returns to growth and how BB Biotech is positioned to take advantage of the current situation in the market amid lower valuations.

Interview with Edison

Dr. Daniel Koller shares his views on the biotech sector in the interview with Edison. He expands on themes like the sector’s ability to outperform the broader equity market as the market moves forward and returns to growth and how BB Biotech is positioned to take advantage of the current situation in the market amid lower valuations.
07.03.2023 - Daniel Koller